| 1 | 
                
                    CD3G
                
             💬
 | [10]  Hematopoietic cell lineage Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Chagas disease, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer | Visilizumab 
                
                    Visilizumab
                
             💬
 | 
                
                    Visilizumab
                
             | [2]  96 96, 97 💬
 | 
| 2 | 
                
                    CD3G
                
             💬
 | [10]  Hematopoietic cell lineage Hematopoietic cell lineage, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Chagas disease, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer | Otelixizumab 
                
                    Otelixizumab
                
             💬
 | 
                
                    Otelixizumab
                
             | [1]  46 46 💬
 |